Sign in
4

Changes in Ownership

Mineralys Therapeutics, Inc. Filed Acc 0001672659-26-000030

Chief Medical Officer sold 8,519 shares at an average $24.20 ($206,151)

  • Chief Medical Officer acquired 8,519 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Rodman David Malcom Chief Medical Officer 2026-06-10 Option exercise 10b5-1 +2,170 $16.00 $34,720 65,613 D
Rodman David Malcom Chief Medical Officer 2026-06-10 Sale 10b5-1 −2,170 $25.00 $54,250 63,443 D
Rodman David Malcom Chief Medical Officer 2026-06-12 Option exercise 10b5-1 +6,349 $1.08 $6,857 69,792 D
Rodman David Malcom Chief Medical Officer 2026-06-12 Sale 10b5-1 −6,349 $23.93 $151,901 63,443 D
Derivatives
Rodman David Malcom Chief Medical Officer 2026-06-10 Option exercise · Stock Option 10b5-1 −2,170 17,365 D
Rodman David Malcom Chief Medical Officer 2026-06-12 Option exercise · Stock Option 10b5-1 −6,349 6,349 D
Open-market sales · 8,519 sh · avg $24.20 · $206,151
Loading xslF345X06/wk-form4_1781301893.xml…